Centene price target raised to $71 from $70 at RBC Capital
RBC Capital raised the firm's price target on Centene to $71 from $70 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Healthcare Services and Managed Care. The firm is expecting payor strength seen since April to sustain amid growing concern over volume and a